Cyclerion Therapeutics Inc (CYCN)
2.84
-0.12
(-3.89%)
USD |
NASDAQ |
May 06, 16:00
2.85
+0.01
(+0.35%)
After-Hours: 20:00
Cyclerion Therapeutics Market Cap: 7.697M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 7.697M |
| May 03, 2024 | 8.008M |
| May 02, 2024 | 7.642M |
| May 01, 2024 | 8.239M |
| April 30, 2024 | 7.670M |
| April 29, 2024 | 8.347M |
| April 26, 2024 | 7.941M |
| April 25, 2024 | 8.239M |
| April 24, 2024 | 7.507M |
| April 23, 2024 | 8.266M |
| April 22, 2024 | 8.266M |
| April 19, 2024 | 9.485M |
| April 18, 2024 | 8.722M |
| April 17, 2024 | 8.722M |
| April 16, 2024 | 8.618M |
| April 15, 2024 | 8.998M |
| April 12, 2024 | 9.133M |
| April 11, 2024 | 8.265M |
| April 10, 2024 | 8.401M |
| April 09, 2024 | 8.157M |
| April 08, 2024 | 8.672M |
| April 05, 2024 | 8.943M |
| April 04, 2024 | 9.187M |
| April 03, 2024 | 8.564M |
| April 02, 2024 | 8.564M |
| Date | Value |
|---|---|
| April 01, 2024 | 8.32M |
| March 28, 2024 | 8.672M |
| March 27, 2024 | 8.348M |
| March 26, 2024 | 8.347M |
| March 25, 2024 | 8.212M |
| March 22, 2024 | 8.266M |
| March 21, 2024 | 8.672M |
| March 20, 2024 | 8.943M |
| March 19, 2024 | 8.401M |
| March 18, 2024 | 8.672M |
| March 15, 2024 | 8.808M |
| March 14, 2024 | 9.106M |
| March 13, 2024 | 8.158M |
| March 12, 2024 | 8.131M |
| March 11, 2024 | 8.407M |
| March 08, 2024 | 8.483M |
| March 07, 2024 | 8.401M |
| March 06, 2024 | 7.588M |
| March 05, 2024 | 7.855M |
| March 04, 2024 | 8.672M |
| March 01, 2024 | 8.578M |
| February 29, 2024 | 8.130M |
| February 28, 2024 | 7.695M |
| February 27, 2024 | 7.249M |
| February 26, 2024 | 7.175M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.670M
Minimum
Nov 27 2023
455.97M
Maximum
May 10 2019
92.99M
Average
69.02M
Median
Jan 05 2022
Market Cap Benchmarks
| Eli Lilly and Co | 728.66B |
| iBio Inc | 6.934M |
| AbbVie Inc | 287.36B |
| Agile Therapeutics Inc | 2.843M |
| NovaBay Pharmaceuticals Inc | 2.739M |
Market Cap Related Metrics
| PS Ratio | 12.39 |
| Price to Book Value | 0.6818 |
| Price | 2.84 |
| Earnings Yield | -106.0% |